Quality by Design Approaches in Pharmaceutical Development and Solid Dosage Forms Production: A Narrative Overview
DOI:
https://doi.org/10.35516/jjps.v16i4.908Keywords:
Quality by Design (QbD), Pharmaceutical Development, Solid Dosage forms, Drug manufacturing, Risk-based approachAbstract
Quality by Design (QbD) is an essential approach to pharmaceutical development and manufacturing that has garnered significant attention in recent years. Quality in services, products, and procedures equates to customer satisfaction. Consequently, it facilitates a transition in the pharmaceutical sector and the Food and Drug Administration (FDA) toward a more scientific, risk-based, comprehensive, and proactive drug development strategy. The pharmaceutical industry is actively seeking new solutions to ensure product quality and efficiency. This paper provides a comprehensive overview of QbD principles and their application in the pharmaceutical industry. The benefits of implementing QbD principles are discussed, encompassing increased efficiency, reduced costs, and improved product quality, safety, and efficacy. As the pharmaceutical industry continues to evolve, QbD will remain a crucial aspect of drug development and manufacturing. This article aims to provide pharmaceutical professionals with a comprehensive understanding of the QbD approach.
References
Singh J. International conference on harmonization of technical requirements for registration of pharmaceuticals for human use. Journal of Pharmacology and Pharmacotherapeutics. 2015; 6(3): 185-7. DOI: https://doi.org/10.4103/0976-500X.162004
Sangshetti JN, Deshpande M, Zaheer Z, Shinde DB, Arote R. Quality by design approach: Regulatory need. Arabian Journal of chemistry. 2017; 10: S3412-S25. DOI: https://doi.org/10.1016/j.arabjc.2014.01.025
Bhutani H, Kurmi M, Singh S, Beg S, Singh B. Quality by design (QbD) in analytical sciences: an overview. Quality Assurance. 2004; 3: 39-45.
Joseph J, Godfrey AB. Juran’s quality handbook. New York: McGraw-Hill; 1998.
Cook J, Cruañes MT, Gupta M, Riley S, Crison J. Quality-by-design: are we there yet? AAPS PharmSciTech. 2014; 15(1): 140-8. DOI: https://doi.org/10.1208/s12249-013-0043-1
O'Connor E. Implementation of a quality risk management approach to commissioning and qualification in the biopharmaceutical industry. 2012.
Woodcock J. The concept of pharmaceutical quality. American Pharmaceutical Review. 2004; 7(6): 10-5.
Beg S, Hasnain MS, Rahman M, Swain S. Introduction to quality by design (QbD): fundamentals, principles, and applications. Pharmaceutical quality by design: Elsevier. 2019; p. 1-17. DOI: https://doi.org/10.1016/B978-0-12-815799-2.00001-0
Raju C, Sivagami B. Development and Validation of a Simple and Sensitive ICP-MS Method for the Quantification of Elemental Impurities in Propafenone Hydrochloride Drug Substance. Jordan Journal of Pharmaceutical Sciences. 2023; 282-300. DOI: https://doi.org/10.35516/jjps.v16i2.364
Food U, Administration D. Pharmaceutical cGMPs for the 21st century—A risk-based approach. Final report. 2004.
Yu LX, Raw A, Lionberger R, Rajagopalan R, Lee LM, Holcombe F, et al. US FDA question-based review for generic drugs: A new pharmaceutical quality assessment system. Journal of Generic Medicines. 2007; 4(4): 239-46. DOI: https://doi.org/10.1057/palgrave.jgm.4950073
Nadpara NP, Thumar RV, Kalola VN, Patel PB. Quality by design (QBD): A complete review. Int J Pharm Sci Rev Res. 2012; 17(2): 20-8.
Lionberger RA, Lee SL, Lee L, Raw A, Yu LX. Quality by design: concepts for ANDAs. The AAPS journal. 2008; 10: 268-76. DOI: https://doi.org/10.1208/s12248-008-9026-7
Callis JB, Illman DL, Kowalski BR. Process analytical chemistry. Analytical Chemistry. 1987; 59(9): 624A-37A. DOI: https://doi.org/10.1021/ac00136a723
Yu LX. Pharmaceutical quality by design: product and process development, understanding, and control. Pharmaceutical research. 2008; 25: 781-91. DOI: https://doi.org/10.1007/s11095-007-9511-1
Gawade A, Chemate S, Kuchekar A. Pharmaceutical Quality by Design: A new approach in product development. Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences. 2013; 2(3): 5-12.
Patel H, Parmar S, Patel B. A comprehensive review on Quality by Design (QbD) in pharmaceuticals. development. 2013; 4(5).
Chandramouli R. Review on Quality by Design Approach (Qbd). Current Trends in Biotechnology and Pharmacy. 2021; 15(4): 447-54.
Gandhi A, Roy C. Quality by design (QbD) in pharmaceutical industry: tools, perspectives and challenges. PharmaTutor. 2016; 4(11): 12-20.
Lunney PD, Cogdill RP, Drennen JK. Innovation in pharmaceutical experimentation Part 1: review of experimental designs used in industrial pharmaceutics research and introduction to Bayesian D-optimal experimental design. Journal of Pharmaceutical Innovation. 2008; 3: 188-203. DOI: https://doi.org/10.1007/s12247-008-9041-3
Kadam VR, Patil M, Pawar VV, Kshirsagar S. A review on: Quality by design (QbD). Asian J Res Pharm Sci. 2017; 7(4): 197-204. DOI: https://doi.org/10.5958/2231-5659.2017.00030.3
Jain S. Quality by design (QBD): A comprehensive understanding of implementation and challenges in pharmaceuticals development. Int J Pharm Pharm Sci. 2014; 6(1): 29-35.
Drakulich A. Critical challenges to implementing QbD: A Q&A with FDA. Pharmaceutical Technology. 2009; 33(10).
Savitha S, Devi K. Quality By Design: A Review. Journal of Drug Delivery and Therapeutics. 2022; 12(2-S): 234-9. DOI: https://doi.org/10.22270/jddt.v12i2-S.5451
Pokharana M, Vaishnav R, Goyal A, Shrivastava A. Stability testing guidelines of pharmaceutical products. Journal of Drug Delivery and Therapeutics. 2018; 8(2): 169-75. DOI: https://doi.org/10.22270/jddt.v8i2.1564
Durakovic B. Design of experiments application, concepts, examples: State of the art. Periodicals of Engineering and Natural Sciences. 2017; 5(3). DOI: https://doi.org/10.21533/pen.v5i3.145
Haruna F, Apeji YE, Oyi AR. Development and Characterization of a Microcrystalline Cellulose-based co-Processed Excipient using Design of Experiment Approach. Jordan Journal of Pharmaceutical Sciences. 2022; 15(4): 553-68. DOI: https://doi.org/10.35516/jjps.v15i4.678
Granato D, de Araújo Calado VM, Jarvis B. Observations on the use of statistical methods in food science and technology. Food Research International. 2014; 55: 137-49. DOI: https://doi.org/10.1016/j.foodres.2013.10.024
Ranga S, Jaimini M, Sharma SK, Chauhan BS, Kumar A. A review on Design of Experiments (DOE). Int J Pharm Chem Sci. 2014; 3(1): 216-24.
Jain S. Quality by design (QBD): A comprehensive understanding of implementation and challenges in pharmaceuticals development. Int J Pharm Pharm Sci. 2014; 6: 29-35.
Jadhav JB, Girawale NN, Chaudhari RA. Quality by Design (QBD) approach used in development of pharmaceuticals. Int J Pure App Biosci. 2014; 2(5): 214-23.
Purohit P, Shah K. QUALITY BY DESIGN (QBD): NEW PARAMETER FOR QUALITY IMPROVEMENT & PHARMACEUTICAL DRUG DEVELOPMENT. Pharma Science Monitor. 2013; 3(3).
Bhattacharya J, Pharm M, Phil M. Quality Risk Management–Understanding and control the risk in pharmaceutical manufacturing industry. International Journal of Pharmaceutical Science Invention. 2015; 4(1): 29-41.
Roy S. Quality by design: A holistic concept of building quality in pharmaceuticals. International Journal of Pharmaceutical and Biomedical Research. 2012; 3(2): 100-8.
de Ruijter VN, Redondo-Hasselerharm PE, Gouin T, Koelmans AA. Quality criteria for microplastic effect studies in the context of risk assessment: a critical review. Environmental Science & Technology. 2020; 54(19): 11692-705. DOI: https://doi.org/10.1021/acs.est.0c03057
Fukuda IM, Pinto CFF, Moreira CdS, Saviano AM, Lourenço FR. Design of experiments (DoE) applied to pharmaceutical and analytical quality by design (QbD). Brazilian journal of pharmaceutical sciences. 2018; 54. DOI: https://doi.org/10.1590/s2175-97902018000001006
Kolekar YM. Understanding of DoE and its advantages in Pharmaceutical development as per QbD Approach. Asian Journal of Pharmacy and Technology. 2019; 9(4): 271-5. DOI: https://doi.org/10.5958/2231-5713.2019.00045.X
Jindal K, Goswami M. SIGNIFICANCE OF DESIGN OF EXPERIMENTS (DoE) IN PHARMACEUTICAL SCIENCES: A BRIEF REVIEW.
Nasr M. FDA’s quality initiatives–An update, 10th APIC/CEFIC. 2006.
Tang Y, Aaps O. Quality by design approaches to analytical methods-FDA perspective. FDA/CDER. 2011.
Somma R. Development knowledge can increase manufacturing capability and facilitate quality by design. Journal of Pharmaceutical Innovation. 2007; 2(3-4): 87-92. DOI: https://doi.org/10.1007/s12247-007-9017-8
Purohit D, Saini M, Pandey P, Tripathy S, Dureja H. Implementation of Quality by Design: A Review. Applied Clinical Research, Clinical Trials and Regulatory Affairs. 2019; 6(2): 99-111. DOI: https://doi.org/10.2174/2213476X06666190117120029
